The possible role of endothelin(s) in cyclosporine: A preparations-induced contraction of guinea pig isolated gallbladder strips

General Pharmacology

Volumn 31, Issue 4, 1998, Pages 607-611

  Erdem, Ş Remzi ^a   Yaşar, Ümit ^a   Tuncer, Meral ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cholestasis; Cyclosporine A; Endothelin; Gallbladder; Sphincter of Oddi

Indexed keywords

BOSENTAN; CYCLOSPORIN A; DRUG VEHICLE; ENDOTHELIN; RICINOMACROGOL; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GALLBLADDER CONTRACTION; GUINEA PIG; MALE; NONHUMAN; ODDI SPHINCTER; PRIORITY JOURNAL;

ANIMALS; CYCLOSPORINE; ENDOTHELINS; FEMALE; GALLBLADDER; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; SPHINCTER OF ODDI; SULFONAMIDES; VEHICLES; VERAPAMIL;

EID: 0032189104     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00051-2     Document Type: Article

References (37)

1. Amorena C., Castro A., Muller A., Villamil M.F. Direct vascular effects in the rat of the vehicles used for the intravenous and oral administration of cyclosporin A. Clin. Sci. 79:1990;149-154.
2. Ballantyne C.M., Podet E.J., Patsch W.P., Harati Y., Appel V., Gotto A.M. Jr., Young J.B. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA. 262:1989;53-56.
3. Bluhm R.E., Frazer M.G., Vore M., Pinson C.W., Badr K.F. Endothelins 1 and 3. potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine Hepatology. 18:1993;961-968.
4. Böhme M., Müller M., Leier I., Jedlitschky G., Keppler D. Cholestasis caused by inhibition of adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology. 107:1994;255-265.
5. Bunchman T.E., Brookshire C.A. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J. Clin. Invest. 88:1991;310-314.
6. Busuttil R.W., Colonna J.O., Hiatt J.R., Brems J.J., Khoury G., Goldstein L.I., Quinones B., Abdul Rasool I.H., Ramming K.P. The first 100 liver transplants at UCLA. Ann. Surg. 206:1987;387-402.
7. Cai W.Q., Gabella G. Innervation of the gallbladder and biliary pathways in the guinea-pig. J. Anat. 136:1983;97-109.
8. Calne R.Y., Thiru S., McMaster P., Dunn D.C., Craddock G.N., Pentlow B.D., Rolles K. Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet. 2:1978;1323-1327.
9. Cohen D.J., Loertscher R., Rubin M.F., Tilney N.L., Carpenter C.B., Strom T.B. Cyclosporine. a new agent for organ transplantation Ann. Intern. Med. 101:1984;667-682.
10. Funch-Jensen P. Sphincter of Oddi motility. Acta Chir. Scand. Suppl. 553:1990;1-35.
11. Gandhi C.R., Stephenson K., Olson M.S. Endothelin, a potent peptide agonist in the liver. J. Biol. Chem. 265:1990;17432-17435.
12. Gocer F., Yaris E., Tuncer M. The action of amyl nitrite and isosorbide dinitrate on the contractility of sphincter of Oddi of guinea-pigs. Gen. Pharmac. 25:1994;995-999.
13. Griffith B.P., Hardesty R.L., Trento A., Lee A., Bohnson H.T. Targeted blood levels of cyclosporin for cardiac transplantation. J. Thorac. Cardiovasc. Surg. 88:1984;952-957.
14. Kon V., Sugiura M., Inagami T., Harvie B.R., Ichikawa I., Hoover R.L. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int. 37:1990;1487-1491.
15. Lerman A., Click R.L., Narr B.J., Wiesner R.H., Krom R.A., Textor S.C., Burnett J.C. Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. Transplanation. 51:1991;646-650.
16. Lo Russo A., Passaquin A.C., Andre P., Skutella M., Rüegg U.T. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction. possible lack of relationship to immunosuppresive activity Br. J. Pharmac. 118:1996;885-892.
17. Moore K.P., Wendon J., Frazer M., Gimson A.E.S., Karani J., Williams R., Badr K.F. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N. Engl. J. Med. 327:1992;1774-1778.
18. Moseley R.H., Johnson T.R., Morrissette J.M. Inhibition of bile acid transport by cyclosporine A in rat liver plasma membrane vesicles. J. Pharmac. Exp. Ther. 253:1990;974-980.
19. Perico N., Ruggenenti P., Gaspari F., Mosconi L., Benigni A., Amuchastegui C.S., Gasparini F., Remuzzi G. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation. 54:1992;56-60.
20. Ptachcinski R.J., Burckart G.J., Venkataramanan R. Cyclosporine. Drug Intell. Clin. Pharm. 19:1985;90-100.
21. Ptachcinski R.J., Venkataramanan R., Burckart G.J. Clinical pharmacokinetics of cyclosporine. Clin. Pharm. 11:1986;107-132.
22. Roman I.D., Monte M.J., Esteller A., Jimenez R. Cholestasis in the rat by means of intravenous administration of cyclosporine vehicle, Cremophor-EL. Transplantation. 48:1989;554-558.
23. Stone B.G., Udani M., Sanghvi A., Warty V., Plocki K., Bedetti C.D., Van Thiel D.H. Cyclosporin A-induced cholestasis. the mechanism in a rat model Gastroenterology. 93:1987;344-351.
24. B receptor. Br. J. Pharmac. 121:1997;433-440.
25. Takeda M., Breyer M.D., Noland T.D., Homma T., Hoover R.L., Inagami T., Kon V. Endothelin-1 receptor antagonist. effects on endothelin- and cyclosporine-treated mesangial cells Kidney Int. 42:1992;1713-1719.
26. Thai B.L., Dumont M., Michel A., Erlinger S., Houssin D. Cholestatic effect of cyclosporine in the rat. an inhibition of bile acid secretion Transplantation. 46:1988;510-512.
27. Toouli J., Dodds W.J., Honda R., Sarna S., Hogan W.J., Komarowski R.A., Linehan J.H., Arndorter R.C. Motor function of the opossum sphincter of Oddi. J. Clin. Invest. 71:1983;208-220.
28. Wagner K., Albrecht S., Neumayer H.H. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem. a prospective randomized study Am. J. Nephrol. 7:1987;287-291.
29. Wagner K., Philipp T.H., Heinemeyer G., Brockmüller F., Roots I., Neumayer H.H. Interaction of cyclosporin and calcium antagonists. Transplant. Proc. 21:1989;1453-1456.
30. Whiting P.H., Thomson A.W., Simpson J.G. Cyclosporine toxicity, metabolism and drug interactions. implications from animal studies Transplant. Proc. 17:1985;134-144.
31. Wyatt A.P. The relationship of the sphincter of Oddi to the stomach, duodenum and gallbladder. J. Physiol. 193:1967;225-243.
32. Yanagisawa M., Masaki T. Molecular biology and biochemistry at the endothelins. Trends Pharmac. Sci. 10:1989;374-378.
33. Yaris E., Tuncer M. Cyclosporin A and Cremophor-EL augment renal vascular responses to various agonists and nerve stimulation. Arch. Int. Pharmacodyn. Ther. 329:1995;405-417.
34. Yaris E., Tuncer M., Ilhan M. Actions of cyclosporin A preparation and Cremophor-EL in rabbit mesenteric artery and thoracic aorta in vitro. Clin. Sci. 83:1992;179-182.
35. Yaris E., Tuncer M., Kayaalp S.O., Ilhan M. Direct vascular smooth muscle contractile effect of cyclosporin A and its vehicle in rabbit isolated arteries. Arch. Int. Pharmacodyn. Ther. 327:1994;166-174.
36. Ziegler K., Polzin G., Frimmer M. Hepatocellular uptake of cyclosporin A by simple diffusion. Biochim. Biophys. Acta. 938:1988;44-50.
37. Zotz R.B., Beste M., Breuer N., Goebell H., Philipp T., Wagner K. Influence of the calcium antagonist nitrendipine on the hepatotoxic effect of cyclosporin A. J. Cardiovasc. Pharmac. 18(Suppl. 1):1991;S82-S83.